L-DOPA ethyl ester to treat Parkinson's disease

Details L-DOPA ethyl ester to treat Parkinson's disease L-DOPA ethyl ester to treat Parkinson's disease

1995-05-17

1997-03-04

Criares, Theodore J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

A61K 3124

Patent

active

056079699

ABSTRACT:
Patients suffering from Parkinson's disease are treated by administering a composition which contains an active ingredient and a pharmaceutically acceptable carrier. The active ingredient comprises L-DOPA ethyl ester in an amount which is at least 97% by weight of the active ingredient and L-DOPA in an amount which is less than 1% by weight of the active ingredient.

REFERENCES:
patent: 3803120 (1974-04-01), Felix
patent: 3939253 (1976-02-01), Bodor et al.
patent: 3961041 (1976-06-01), Nishimura et al.
patent: 4035507 (1977-07-01), Bodor et al.
patent: 4663349 (1987-05-01), Repta
patent: 4826875 (1989-05-01), Chiesi
patent: 4916151 (1990-04-01), Bey et al.
D.R. Cooper et al., "L-Dopa esters as potential prodrugs; behavioural actty in experimental models of Parkinson's disease"; J. Pharm. Pharmacol.; vol. 39: No.8; pp. 627-635.
Cooper, D.R., et al., Clin. Neuropharmacol. (1984) 7:89-98 .
Fix, J.A., et al., Pharm. Res. (1989) 6:501-505.
Juncos, J.L., et al., Neurology (1987) 37:1242-1245.
Lai, C.M., et al., J. Pharm. Sci. (1973) 62:510-511.
Yoshimasa Tomiuchi, et al. Bull. Chem. Soc. Jpn. (Oct. 1992) 65:2599-2603.

Affiliated with

Also associated with

Rating

L-DOPA ethyl ester to treat Parkinson's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with L-DOPA ethyl ester to treat Parkinson's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and L-DOPA ethyl ester to treat Parkinson's disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2146289